Myricetin ameliorates high glucose‐induced endothelial dysfunction in human umbilical vein endothelial cells

Azadeh Aminzadeh,Hamideh Bashiri
DOI: https://doi.org/10.1002/cbf.3442
2019-11-05
Cell Biochemistry and Function
Abstract:Endothelial dysfunction is recognized as the initial detectable stage of cardiovascular disease, a serious complication of diabetes. In this study, we evaluated effects of myricetin on high glucose (HG)‐elicited oxidative damage in human umbilical vein endothelial cells (HUVECs). The cells were pre‐incubated with myricetin and then treated with HG to induce apoptosis. The effect of myricetin on viability was investigated by MTT assay. The levels of lipid peroxidation (LPO) were determined by thiobarbituric acid (TBA) method. The protein expression of Bax, Bcl‐2 and caspase‐3 was measured by western blot analysis. Moreover, the effect of myricetin on total antioxidant capacity (TAC) and total thiol molecules was also determined. Our results showed that myricetin was able to markedly restore the viability of endothelial cells under oxidative stress. Myricetin reduced HG‐caused increase in LPO levels. Also, TAC and total thiol molecules were notably elevated by myricetin. Incubation with myricetin decreased the protein expression levels of Bax, whereas it increased the expression levels of the Bcl‐2, compared with HG treatment alone. Furthermore, myricetin significantly decreased cleaved caspase‐3 protein expression. It is concluded that myricetin may protect HUVECs from oxidative stress induced by HG via increasing cell TAC and reducing Bax/Bcl‐2 protein ratio, and caspase‐3 expression.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?